Abbott, market leader in premium cardiac stents, may withdraw its products from India following the National Pharmaceutical Pricing Authority’s (NPPA’s) order to cap prices last week.
NPPA set a price cap of Rs 7,260 on bare metal stents and Rs 29,600 on drug eluting and biodegradable ones.
“Abbott may withdraw its Xience Alpine and its dissolving stent, Absorb,” said a distributor on the basis of informal communication. Abbott’s dissolving stent was priced at a little less than Rs 2 lakh before the price cap and the import price was Rs 42,125.
"Abbott does not comment on market speculation," said a